CPDA structure
|
Common Name | CPDA | ||
---|---|---|---|---|
CAS Number | 1415834-63-7 | Molecular Weight | 388.79500 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C20H15ClF2N2O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of CPDACPDA is a novel potent SH2 domain-containing inositol phosphatase 2 (SHIP2) inhibitor that can effectively ameliorate insulin resistance in 3T3-L1 adipocytes.Target: SHIP2in vitro: CPDA was found to enhance insulin signaling.in vivo: CPDA greatly improves abnormal glucose metabolism in diabetic animals. CPDA was also found to improve the abnormal glucose metabolism in db/db mice. |
Name | cpda |
---|---|
Synonym | More Synonyms |
Description | CPDA is a novel potent SH2 domain-containing inositol phosphatase 2 (SHIP2) inhibitor that can effectively ameliorate insulin resistance in 3T3-L1 adipocytes.Target: SHIP2in vitro: CPDA was found to enhance insulin signaling.in vivo: CPDA greatly improves abnormal glucose metabolism in diabetic animals. CPDA was also found to improve the abnormal glucose metabolism in db/db mice. |
---|---|
Related Catalog | |
References |
Molecular Formula | C20H15ClF2N2O2 |
---|---|
Molecular Weight | 388.79500 |
Exact Mass | 388.07900 |
PSA | 51.22000 |
LogP | 4.84640 |
Storage condition | 2-8℃ |
N-[4-[(4-Chlorophenyl)methoxy]-2-pyridinyl]-2,6-difluoro-benzeneacetamide |